Linoleic acid reduces vascular reactivity and improves the vascular dysfunction of the small mesentery in hypertension

J Nutr Biochem. 2018 Dec:62:18-27. doi: 10.1016/j.jnutbio.2018.07.016. Epub 2018 Aug 17.


We aimed to investigate the effect of linoleic acid (LA) treatment on the blood pressure and function of mesenteric resistance arteries (MRA) in spontaneous hypertensive rats (SHR). Male SHR were treated daily with LA (15 mg/kg) or vehicle (control) for 15 days. Compared with controls, LA treatment decreased blood pressure and showed the following in MRA: (1) increased lumen and external diameter, (2) decreased wall:lumen ratio and wall thickness, (3) decreased stiffness and (4) less collagen deposition. LA treatment reduced the contractile response to phenylephrine, although there were no changes observed in MRA in regard to the acetylcholine or sodium nitroprusside responses. Incubation with L-NAME left-shifted the reactivity to phenylephrine only in the MRA treated group, suggesting that LA treatment can improve NO bioavailability. This result was accompanied by an increase "in situ" NO production. Incubation with tiron decreased vascular reactivity to phenylephrine in MRA in LA rats, which was accompanied by decreased superoxide anion production. Moreover, incubation with indomethacin (non-selective COX inhibitor, 10 μM), NS 398 (COX-2 specific inhibitor, 1 μM), furegrelate (TXA2 synthase inhibitor, 1 μM), SQ 29.548 (TP receptor antagonist, 1 μM) and SC 19220 (EP1 receptor antagonist, 10 μM) reduced the vasoconstrictor responses to phenylephrine in MRA in the treated group. These results were accompanied by a reduction in COX-2 protein expression. In conclusion, these findings show that LA treatment decreases blood pressure. In addition, the improvement of endothelial dysfunction and structural changes in this hypertension model may be responsible for the reduction in blood pressure.

Keywords: Hypertension; Linoleic acid; Mesenteric resistance arteries; Vascular function; Vascular remodeling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antihypertensive Agents / pharmacology
  • Blood Pressure / drug effects
  • Cyclooxygenase 2 / metabolism
  • Hypertension / drug therapy
  • Hypertension / physiopathology*
  • Linoleic Acid / pharmacology*
  • Male
  • Mesenteric Arteries / drug effects*
  • Mesenteric Arteries / physiopathology
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Oxidative Stress / drug effects
  • Oxidative Stress / physiology
  • Phenylephrine / pharmacology
  • Prostaglandins / metabolism
  • Rats, Inbred SHR
  • Vascular Remodeling / drug effects
  • Vasoconstriction / drug effects
  • Vasodilation / drug effects


  • Antihypertensive Agents
  • Prostaglandins
  • Phenylephrine
  • Linoleic Acid
  • Cyclooxygenase 2
  • Ptgs2 protein, rat
  • NG-Nitroarginine Methyl Ester